(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBD introduced) (NP (NP (DT a) (JJ novel) (NN feature) (NN extraction) (NN approach)) (, ,) (VP (VBN named) (S (NP (S (NP (JJ exclusive) (NN autoencoder))) (PRN (-LRB- -LRB-) (NP (NNP XAE)) (-RRB- -RRB-))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT a) (JJ supervised) (NN version)) (PP (IN of) (NP (NP (NN autoencoder)) (PRN (-LRB- -LRB-) (NP (NNP AE)) (-RRB- -RRB-)))) (, ,) (ADJP (JJ able) (S (VP (TO to) (VP (ADVP (RB largely)) (VB improve) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (JJ nucleus) (NN detection) (CC and) (NN classification))) (PP (IN on) (NP (NN hematoxylin) (CC and) (NN eosin) (PRN (-LRB- -LRB-) (NNP H) (CC &) (NNP E) (-RRB- -RRB-)) (JJ histopathological) (NNS images)))))))))))))) (. .))
(S (NP (DT The) (VBN proposed) (NN XAE)) (VP (MD can) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (DT any) (JJ AE-based) (NN algorithm))) (, ,) (ADVP (ADVP (RB as) (RB long)) (SBAR (IN as) (S (NP (DT the) (NN data) (NNS labels)) (VP (VBP are) (ADVP (RB also)) (VP (VBN provided) (PP (IN in) (NP (DT the) (NN feature) (NN extraction) (NN phase))))))))))) (. .))
(S (PP (IN In) (NP (DT the) (NNS experiments))) (, ,) (NP (PRP we)) (VP (VP (VBD evaluated) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (NP (DT an) (NN approach)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (DT an) (NN XAE)) (CC and) (NP (NP (DT a) (ADJP (RB fully) (VBN connected)) (JJ neural) (NN network)) (PRN (-LRB- -LRB-) (NP (NNP FCN)) (-RRB- -RRB-))))))))))))) (CC and) (VP (VBN compared) (PP (IN with) (NP (DT some) (JJ AE-based) (NNS methods))))) (. .))
(S (PP (IN For) (NP (NP (DT a) (JJ nucleus) (NN detection) (NN problem)) (PRN (-LRB- -LRB-) (VP (VBN considered) (PP (IN as) (NP (DT a) (JJ nucleus/non-nucleus) (NN classification) (NN problem)))) (-RRB- -RRB-)) (PP (IN on) (NP (NN breast) (NN cancer) (NNP H) (CC &) (NNP E) (NNS images))))) (, ,) (NP (NP (DT the) (NNP F-score)) (PP (IN of) (NP (DT the) (VBN proposed) (NNP XAE+FCN) (NN approach)))) (VP (VBD achieved) (NP (CD 96.64) (NN %)) (SBAR (IN while) (S (NP (DT the) (NN state-of-the-art)) (VP (VBD was) (PP (IN at) (NP (CD 84.49) (NN %))))))) (. .))
(FRAG (IN For) (NP (NP (NP (JJ nucleus) (NN classification)) (PP (IN on) (NP (JJ colorectal) (NN cancer) (NNP H) (CC &) (NNP E) (NNS images)))) (, ,) (PP (IN with) (NP (NP (DT the) (NNS annotations)) (PP (IN of) (NP (NP (CD four) (NNS categories)) (PP (IN of) (NP (ADJP (JJ epithelial) (, ,) (JJ inflammatory) (, ,) (JJ fibroblast) (CC and) (JJ miscellaneous)) (NN nuclei)))))))) (. .))
(S (NP (NP (DT The) (NNP F-score)) (PP (IN of) (NP (DT the) (VBN proposed) (NN method)))) (VP (VBD reached) (NP (CD 70.4) (NN %))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBD proposed) (NP (DT a) (JJ lymphocyte) (NN segmentation) (NN method))) (. .))
(S (PP (IN In) (NP (NP (DT the) (NN step)) (PP (IN of) (NP (JJ lymphocyte) (NN detection))))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VP (VBN compared) (PP (IN with) (NP (NN cutting-edge) (NN technology)))) (CC and) (VP (VBD gained) (NP (VBN improved) (NN performance)) (PP (PP (IN from) (NP (CD 90) (NN %))) (PP (TO to) (NP (CD 98.67) (NN %))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBD proposed) (NP (NP (DT an) (NN algorithm)) (PP (IN for) (NP (JJ lymphocyte) (NN segmentation))) (PP (VBN based) (PP (IN on) (NP (JJ nucleus) (NN detection) (CC and) (NN classification)))))) (. .))
(S (NP (DT The) (JJ obtained) (NNP Dice) (NN coefficient)) (VP (VBD achieved) (NP (CD 88.31) (NN %)) (SBAR (IN while) (S (NP (DT the) (JJ cutting-edge) (NN approach)) (VP (VBD was) (PP (IN at) (NP (CD 74) (NN %))))))) (. .))
